Clinical Trials Browser

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03467386 2026-02-17

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Phase 1 Suspended

56 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06348147 2026-02-17

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Phase 2 Suspended

39 enrolled

Plasma cell

Multiple Myeloma

NCT07071961 2026-02-17

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Phase 2 Suspended

16 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03065062 2026-02-13

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Phase 1 Suspended

75 enrolled

GastrointestinalGynecologicHead & Neck

Head and Neck Neoplasms, Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms

NCT03164460 2026-02-13

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Phase 2 Suspended

68 enrolled

Head & Neck

Recurrent Head and Neck Carcinoma

NCT06211933 2026-02-12

PULS

Phase 1/2 Suspended

26 enrolled

Tumor-Agnostic

Neoplasms

NCT05928806 2026-02-11

ARCITECT

Phase 2 Suspended

120 enrolled

Genitourinary

Advanced Renal Cell Carcinoma

NCT06213298 2026-02-11

Effect of Kava on Anxiety and Stress in Cancer Survivors

Phase EARLY_PHASE1 Suspended

43 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT07300319 2026-02-11

CAN

Phase NA Suspended

40 enrolled

Fatigue, Neoplasms

NCT03316573 2026-02-10

Pembrolizumab in Neoplasms or Lymphomas

Phase 2 Suspended

18 enrolled 16 charts

LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

NCT05428852 2026-02-10

Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases

Phase NA Suspended

24 enrolled

CNS

Brain Neoplasms

NCT05546879 2026-02-10

Liver-NET1

Phase 1 Suspended

43 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06968195 2026-02-10

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Phase 1 Suspended

24 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04969146 2026-02-09

A Sleep Intervention for Cancer Patients and Their Caregivers

Phase NA Suspended

50 enrolled

Depression, Sleep Initiation and Maintenance Disorders

NCT06492707 2026-02-09

DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial

Phase 1 Suspended

20 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Suspended

600 enrolled

Genitourinary

Prostatic Neoplasms

NCT04850495 2026-02-06

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Phase 1 Suspended

38 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse